In April 2025, Monte Rosa presented preclinical data on the potential of its highly selective CDK2-directed molecular glue degrader, MRT-51443, to treat HR-positive/HER2-negative breast cancer at the ...

Fuelling inclusion, wellness, and football passion of all ages HONG KONG, Aug. 7, 2025 /PRNewswire/ -- As the proud Official Global Training Partner of Liverpool FC (LFC), AXA Hong Kong and Macau (AXA ...